Cefditoren contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Cefditoren}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SPECTRACEF (CEFDITOREN PIVOXIL) TABLET, FILM COATED SPECTRACEF ...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Contraindications== | |||
SPECTRACEF® is contraindicated in patients with known allergy to the cephalosporin class of antibiotics or any of its components. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SPECTRACEF (CEFDITOREN PIVOXIL) TABLET, FILM COATED SPECTRACEF (CEFDITOREN PIVOXIL) TABLET, FILM COATED [CORNERSTONE THERAPEUTICS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f732ed2f-48b9-4331-87ab-81b5fbe728aa | publisher = | date = | accessdate = }}</ref> | SPECTRACEF® is contraindicated in patients with carnitine deficiency or inborn errors of metabolism that may result in clinically significant carnitine deficiency, because use of SPECTRACEF® causes renal excretion of carnitine. (See PRECAUTIONS, General.) | ||
SPECTRACEF® tablets contain sodium caseinate, a milk protein. Patients with milk protein [[hypersensitivity]] (not lactose intolerance) should not be administered SPECTRACEF®.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SPECTRACEF (CEFDITOREN PIVOXIL) TABLET, FILM COATED SPECTRACEF (CEFDITOREN PIVOXIL) TABLET, FILM COATED [CORNERSTONE THERAPEUTICS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f732ed2f-48b9-4331-87ab-81b5fbe728aa | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 01:27, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Contraindications
SPECTRACEF® is contraindicated in patients with known allergy to the cephalosporin class of antibiotics or any of its components.
SPECTRACEF® is contraindicated in patients with carnitine deficiency or inborn errors of metabolism that may result in clinically significant carnitine deficiency, because use of SPECTRACEF® causes renal excretion of carnitine. (See PRECAUTIONS, General.)
SPECTRACEF® tablets contain sodium caseinate, a milk protein. Patients with milk protein hypersensitivity (not lactose intolerance) should not be administered SPECTRACEF®.[1]
References
Adapted from the FDA Package Insert.